Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(11)
•••
Post by Piperdoonon Jul 04, 2018 6:08pm
52 Views
Post# 28269565

Kaly

Kaly
I see they are also down today. Any chance that the cbd market is getting squeezed By BIG pharmaceutical company. KALY is (for those who may not know) Developing cbd drugs for use to treat people Suffering from issues after bone marrow transplant. I wonder how a company like that will supply A steady pharmaceutical grade cbd?? I was on their website and did not see anything related to them growing or supplying their own CBD. It would be a great Supply deal if they knew someone who had an API. Anyone? I happened to stumble across this on the stockhouse advertising as I had no idea who kaly was. I guess my point is, they had an even crappier day (11.4%) down. Seems like cbd might be a target Right now.... Hold strong
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities